WO2011087222A3 - 항암 펩타이드 서열 - Google Patents

항암 펩타이드 서열 Download PDF

Info

Publication number
WO2011087222A3
WO2011087222A3 PCT/KR2010/009358 KR2010009358W WO2011087222A3 WO 2011087222 A3 WO2011087222 A3 WO 2011087222A3 KR 2010009358 W KR2010009358 W KR 2010009358W WO 2011087222 A3 WO2011087222 A3 WO 2011087222A3
Authority
WO
WIPO (PCT)
Prior art keywords
anticancer peptide
anticancer
peptide sequence
host cell
recombinant vector
Prior art date
Application number
PCT/KR2010/009358
Other languages
English (en)
French (fr)
Other versions
WO2011087222A2 (ko
Inventor
백성희
김근일
이지민
Original Assignee
서울대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서울대학교 산학협력단 filed Critical 서울대학교 산학협력단
Priority to EP10843287.3A priority Critical patent/EP2524926B1/en
Publication of WO2011087222A2 publication Critical patent/WO2011087222A2/ko
Publication of WO2011087222A3 publication Critical patent/WO2011087222A3/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 RORα 유도체로부터 기원되는 항암 펩타이드에 관한 것으로서, 상기 항암 펩타이드를 암호화하는 유전자, 상기 유전자를 포함하는 재조합벡터, 상기 재조합벡터로 형질전환된 숙주세포, 상기 숙주세포를 이용한 항암제 생산 방법에 관한 것이다. 상기 항암 펩타이드는 암 특히 전립선암과 대장암의 치료 및 예방에 이용될 수 있다.
PCT/KR2010/009358 2010-01-12 2010-12-27 항암 펩타이드 서열 WO2011087222A2 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10843287.3A EP2524926B1 (en) 2010-01-12 2010-12-27 Anticancer peptide sequence

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0002910 2010-01-12
KR1020100002910A KR101815322B1 (ko) 2010-01-12 2010-01-12 항암 펩타이드 서열

Publications (2)

Publication Number Publication Date
WO2011087222A2 WO2011087222A2 (ko) 2011-07-21
WO2011087222A3 true WO2011087222A3 (ko) 2011-11-10

Family

ID=44304765

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/009358 WO2011087222A2 (ko) 2010-01-12 2010-12-27 항암 펩타이드 서열

Country Status (3)

Country Link
EP (1) EP2524926B1 (ko)
KR (1) KR101815322B1 (ko)
WO (1) WO2011087222A2 (ko)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426455B1 (ko) * 2000-04-25 2004-04-13 김진우 인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 이를포함하는 발현 벡터 및 이 벡터로 형질전환된 세포
KR20050121694A (ko) * 2003-03-24 2005-12-27 더 스크립스 리서치 인스티튜트 종양 성장 억제 ｄｎａ 백신 및 이의 사용 방법
KR20060003903A (ko) * 2003-05-05 2006-01-11 이스티투토 디 리세르쉐 디 비올로지아 몰레콜라레 피. 안젤레티에스.피.에이. 사람 암배아 항원을 암호화하는 합성 유전자 및 이의 용도
KR20090092245A (ko) * 2008-02-26 2009-08-31 영인프런티어(주) 인산화된 단백질에 특이적으로 결합하는 항체를 이용하여 인산화된 단백질에 의한 세포 내 신호 전달을 조절하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006273760A (ja) * 2005-03-29 2006-10-12 Sony Corp Ｂｍａｌ１の発現誘導を促進するＲＯＲα
KR20090001519A (ko) 2007-04-23 2009-01-09 김광수 에스/마임을 이용한 전자메일 보안 강화방법
WO2009126894A2 (en) * 2008-04-11 2009-10-15 Massachusetts Eye And Ear Infirmary Methods and compositions for the diagnosis and treatment of angiogenic disorders
KR101085602B1 (ko) * 2009-01-08 2011-11-22 서울대학교산학협력단 ＲＯＲα를 이용한 항암제 스크리닝 방법

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426455B1 (ko) * 2000-04-25 2004-04-13 김진우 인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 이를포함하는 발현 벡터 및 이 벡터로 형질전환된 세포
KR20050121694A (ko) * 2003-03-24 2005-12-27 더 스크립스 리서치 인스티튜트 종양 성장 억제 ｄｎａ 백신 및 이의 사용 방법
KR20060003903A (ko) * 2003-05-05 2006-01-11 이스티투토 디 리세르쉐 디 비올로지아 몰레콜라레 피. 안젤레티에스.피.에이. 사람 암배아 항원을 암호화하는 합성 유전자 및 이의 용도
KR20090092245A (ko) * 2008-02-26 2009-08-31 영인프런티어(주) 인산화된 단백질에 특이적으로 결합하는 항체를 이용하여 인산화된 단백질에 의한 세포 내 신호 전달을 조절하는 방법

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2524926A4 *

Also Published As

Publication number Publication date
WO2011087222A2 (ko) 2011-07-21
KR101815322B1 (ko) 2018-01-05
EP2524926A4 (en) 2013-05-22
EP2524926B1 (en) 2016-03-09
KR20110082954A (ko) 2011-07-20
EP2524926A2 (en) 2012-11-21

Similar Documents

Publication Publication Date Title
WO2013006544A8 (en) Methods for making multimeric polypeptides
WO2014018563A3 (en) Methods for the treatment of cancer
MY180714A (en) Factor viii chimeric and hybrid polypeptides, and methods of use thereof
EP4253534A3 (en) Alpha-amylase variants and polynucleotides encoding same
MX2013007997A (es) Polipeptidos que tienen actividad de incremento celulolitico y polinucleotidos que codifican para los mismos.
MX353621B (es) Variantes de alfa-amilasa.
MX355356B (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
WO2012146171A9 (en) Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
MX337985B (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
EP3543333A3 (en) Method for screening alpha-amylases
AU2010325787A8 (en) Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof
IN2014CN04586A (ko)
EA033110B1 (ru) Химерный рецептор антигена, направленный на антиген созревания b-клеток, кодирующая его нуклеиновая кислота, соответствующие экспрессионный вектор, клетка-хозяин, применения и способы
MX337919B (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
EP4276200A3 (en) Fgfr-tacc fusion proteins and methods thereof
MX2012011774A (es) Polipeptidos que tienen actividad de glucoamilasa y polinucleotidos que codifican los mismos.
MX337984B (es) Variantes de alfa amilasa y polinucleotidos que codifican la misma.
HUE049207T2 (hu) Normál és tumorsejtek kismolekulás TRAIL-génindukciója rákellenes terápiaként
MX337913B (es) Polipeptidos que tienen actividad celobiohidrolasa y polinucleotidos que codifican los mismos.
EP2586494A4 (en) BOLUS, METHOD FOR MANUFACTURING BOLUS, PARTICLE BEAM THERAPY DEVICE, AND THERAPY PLANNING DEVICE
EP2647721A4 (en) Peptide with safer secondary structure, peptide library, and production methods for same
MX2013004353A (es) Produccion recombinante de n-propanol e isopropanol.
WO2013023084A3 (en) Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells
TN2011000524A1 (en) Antibodies specific to cadherin -17
WO2012054084A3 (en) Antibodies

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010843287

Country of ref document: EP